Our Mission

To make prescription drugs more affordable for all Americans. CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for out-of-control drug prices and provide more affordable choices for patients. We believe in market-based reforms that address the underlying causes of high drug prices in the U.S. through increased transparency, competition, and value.

Learn More

CSRXP COMMENDS PRESIDENT BIDEN FOR HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE AND EGREGIOUS PRICING ON BRAND NAME INHALERS

President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press Conference Highlighting Big Pharma’s Anti-Competitive Practices and Price Hikes on Inhalers Washington, D.C. – The

04-3-2024 Read More

Dose of Reality: CBO Confirms Big Pharma’s Egregious Prices on Weight Loss Drugs Are Unsustainable

CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings from “Reducing Other Health Care Spending” In case you missed it, the Congressional Budget Office (CBO) recently

03-22-2024 Read More

THEN VS. NOW: PFIZER LATEST BIG PHARMA GIANT TO ACCIDENTALLY DEBUNK INDUSTRY’S OWN DOOM-AND-GLOOM INNOVATION RHETORIC

Big Pharma Exec Downplays “Modest” Drug Pricing Solutions That CEO Previously Claimed Would Reduce R&D and Called “Gun to Your Head” Big Pharma can’t seem to keep its story straight.

03-7-2024 Read More

View All

The Crisis

Drug prices are out-of-control. At a time when one-in-four Americans cannot afford their medication, Big Pharma is posting record profits – doubling down on monopolistic tactics to game America’s patent system, prevent generic and biosimilar competition and patient choice and pad their bottom lines.

No patient should ever have to choose between paying for their daily needs or taking the medicine they need to live. Every person deserves access to the medications they need at a price they can afford, especially those who can least afford them.

 

Learn More

Solutions

Americans deserve choice and control over their health. We must all work together to promote competition and increase access to high-quality, affordable treatments and cures for patients. It’s time for real solutions that can deliver more choices, more competition, and lower drug prices by addressing the root causes of price gouging:

Affordability: Too often patients experience the unfortunate and unfair choice between purchasing the medications they need to be well and paying for other necessities. Patients should never be presented with such a choice – especially today with so many people across the U.S. experiencing significant health and economic hardship due to the COVID-19 pandemic. Measures must be taken to improve prescription drug affordability for patients and taxpayers alike, especially while the nation continues to battle the COVID-19 pandemic and everyone across the U.S. will need access to acceptably-priced and affordable virus countermeasures.

Transparency: Patients deserve open and honest drug pricing – clear and transparent information about the true costs of treatment, how manufacturers set prices and the actual cost of bringing drugs to market, particularly for high-cost drugs. Improving pricing transparency will enable patients to become actively involved in their healthcare decision-making and put pressure on Big Pharma to lower the prices of their excessively costly drugs.

Competition: Pharmaceutical companies today abuse the patent system to prevent more affordable drugs from disrupting their monopolies over the drug marketplace. Bringing more competition to the prescription drug market will give consumers more choices and more control – resulting in lower prices and improved access.

Value: Patients deserve reliable information regarding whether a drug’s “therapeutic outcome” – or its health benefit – is in line with its price. This information is critical to moving America’s prescription drug market toward a system that empowers doctors and patients to choose medications based on the value they provide – not the “value” set by drug manufacturers.

Learn More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.

Who we are

The Campaign for Sustainable Rx Pricing (CSRxP) is a broad-based coalition of leaders – physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses – promoting bipartisan, market-based solutions to lower drug prices in America.

Keep the Conversation Going

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

Thank you Sen. Lisa Murkowski for co-sponsoring The Affordable Prescriptions for Patients Act (S. 150). This bipartisan, market-based solution will help lower Rx drug prices by holding #BigPharma accountable for patent abuse to foster greater competition. ... See MoreSee Less

3 days ago